CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 16,400 shares at an average $36.46 ($597,976)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 98,660 shares at an average $35.54 ($3,506,278)
- 4 Planned sale CHIEF CORP. & COMM. OFFICER sold 3,523 shares at $35.31 ($124,397)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 15,091 shares at $35.50 ($535,731)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 11,000 shares at $34.84 ($383,240)
- 4 Shares withheld for taxes CHIEF CORP. & COMM. OFFICER gave up 3,300 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 3,676 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,820 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 14,160 shares (to pay taxes)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Planned sale CHIEF OPERATING OFFICER sold 16,200 shares at an average $33.77 ($547,141)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 177,769 shares at an average $32.96 ($5,859,815)
Page 7 of 39 · 778 filings